Alkem Laboratories (ALKEM) Share Price Falls 2.13% Today to Rs 5,298.75

Published:   24 September 2026 at 1:49:12 PM IST

Alkem Laboratories Share Price fell today, with the stock trading at Rs 5,298.75, down 2.13% from the previous close, while market capitalisation stood at Rs 63,813.63 crore. The move is visible in today's price action, but the supplied data does not establish a company-specific catalyst. That makes this Alkem Laboratories Share Price update a data-led market note rather than a reasoned event story.

The current decline comes after a previous close of Rs 5,414.15 and places Alkem Laboratories Stock News firmly in focus for traders and long-term investors tracking Alkem Laboratories Share Price Today. The stock also finished below its day open of Rs 5,414.80, and the intraday range stretched from Rs 5,285 to Rs 5,444.90. The verified turnover was Rs 1.28 crore. In the context of large-cap companies, the fall is notable because it occurred without any disclosed trigger in the supplied feed. For readers comparing Alkem Laboratories Share Price with broader Healthcare names, the next sections frame the move using valuation, profitability and sector data only.

Alkem Laboratories (ALKEM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 5,298.75
Previous Close	Rs 5,414.15
Today's Move	-Rs 115.40 (-2.13%)
Open	Rs 5,414.8
High	Rs 5,444.9
Low	Rs 5,285
Turnover	Rs 1.28 crore
Market Capitalisation	Rs 63,813.63 crore
Market Cap Category	Large Cap

Alkem Laboratories Share Price Today shows a session where the stock moved from an open of Rs 5,414.80 to a close of Rs 5,298.75. The day high was Rs 5,444.90 and the day low was Rs 5,285, which means the close finished close to the lower end of the session range. The absolute fall of Rs 115.40 matches the 2.13% decline against the previous close of Rs 5,414.15.

The turnover was Rs 1.28 crore, which is a factual traded-value reading and not an explanation for the move. With marketCapCategory supplied as Large Cap and market capitalisation at Rs 63,813.63 crore, Alkem Laboratories Share Price remains that of a sizeable listed healthcare company. Since the event data confirms a same-day price fall but does not establish why it happened, Alkem Laboratories Stock News today is best read as a verified price event first and an interpretation second. That sets up the need to examine whether the broader numbers support the current Alkem Laboratories Share Price level.

Alkem Laboratories (ALKEM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 63,813.63 crore
P/E Ratio	30x
P/B Ratio	4.53x
ROE	18.29%
ROCE	21.28%
EPS	Rs 180.45
Book Value Per Share	Rs 1,196.51
Dividend Yield	0.98%

Alkem Laboratories Fundamental Analysis points to a business with a market capitalisation of Rs 63,813.63 crore and an enterprise-value-like valuation profile that can be read through standard ratios supplied here. The stock trades at a P/E ratio of 30 and a P/B ratio of 4.53, while ROE is 18.29% and ROCE is 21.28%. Those return ratios show the company generating double-digit returns on equity and capital employed.

EPS stands at Rs 180.45, which means earnings attributable to each share are meaningful in relation to the current price. Book value is Rs 1,196.51 per share, giving a per-share accounting reference point, while dividend yield is 0.98%, a historical distribution metric at the current price. In the same frame, the valuation needs to be read alongside profit quality rather than in isolation. For Alkem Laboratories Share Price, the supplied fundamentals do not explain the day's decline, but they do show a profitable large-cap healthcare company with mid-range valuation multiples and strong return ratios. That is useful context for Alkem Laboratories Stock Analysis and Alkem Laboratories Share Price News alike.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	30x
Benchmark Median P/E	31.9x
Benchmark Average P/E	50.01x
Benchmark P/E Range	3.48x to 762.66x
Company P/B Ratio	4.53x
Benchmark Median P/B	3x
Benchmark Average P/B	4.38x
Company ROE	18.29%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.65%
Company ROCE	21.28%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.26%
Company Market Capitalisation	Rs 63,813.63 crore
Benchmark Median Market Cap	Rs 761.61 crore
Benchmark Average Market Cap	Rs 14,299.75 crore

Alkem Laboratories operates in Healthcare and the Pharmaceuticals & Drugs industry, where the benchmark scope supplied is the same industry and covers 200 companies. In that set, Alkem Laboratories Share Price is associated with a company P/E of 30 versus a benchmark median of 31.9 and an average of 50.01. That places the stock below the median and well below the average on this metric. The company P/B of 4.53 is above the benchmark median of 3 and above the benchmark average of 4.38.

On profitability, ROE of 18.29% is above the benchmark median of 11.7% and benchmark average of 10.65%, while ROCE of 21.28% is above the benchmark median of 13.46% and benchmark average of 13.26%. The benchmark market capitalisation median is Rs 761.61 crore and the average is Rs 14,299.75 crore, while Alkem Laboratories market capitalisation is Rs 63,813.63 crore, clearly above both. This sector context supports a structured Alkem Laboratories Fundamental Analysis and helps place the current Alkem Laboratories Share Price within the wider Pharmaceuticals & Drugs universe.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,42,437.37	37	5.17	14.85	19.11
Divi's Laboratories	DIVISLAB	2,48,053.84	87.1	14.42	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,841.6	86.85	21.1	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,810.19	25.85	4.33	19.69	21.39
Cipla	CIPLA	1,11,565.25	33.08	3.17	11.83	16

Among the supplied peers, Alkem Laboratories sits in the upper tier by market capitalisation, below Sun Pharmaceutical Industries at Rs 4,42,437.37 crore and ahead of several other listed names in the peer set. Its P/E ratio of 30 is lower than Sun Pharma at 37, far below Divi's Laboratories at 87.1 and Torrent Pharmaceuticals at 86.85, and slightly above Zydus Lifesciences at 25.85.

On return ratios, Alkem Laboratories ROE of 18.29% is above Sun Pharma's 14.85% and Cipla's 11.83%, but below Torrent Pharmaceuticals at 26.76% and Lupin at 27.11%. ROCE of 21.28% is above Sun Pharma, Cipla, Dr. Reddy's Laboratories and Aurobindo Pharma, and close to Divi's Laboratories and Zydus Lifesciences. For Alkem Laboratories Share Price, the peer set suggests a company that is not the cheapest in the group on every measure, but one that combines a large market cap with solid profitability ratios. That comparison is central to Alkem Laboratories Share Price Today and Alkem Laboratories Stock News analysis.

Why Investors Are Watching Alkem Laboratories

• Alkem Laboratories Share Price fell 2.13% today to Rs 5,298.75 from Rs 5,414.15.
• The session range was Rs 5,285 to Rs 5,444.90, with opening price at Rs 5,414.80.
• Market capitalisation stood at Rs 63,813.63 crore, and the company is classified as Large Cap.
• Valuation stood at a P/E of 30 and a P/B of 4.53, with EPS at Rs 180.45 and book value at Rs 1,196.51.
• ROE was 18.29% and ROCE was 21.28%, both above the supplied industry benchmark median.

About Alkem Laboratories

Alkem Laboratories is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied classification places the company inside a large listed healthcare peer set used in this article. Its market capitalisation is Rs 63,813.63 crore and the stock is tracked on NSE and BSE in the context of Alkem Laboratories Share Price and Alkem Laboratories Share Price Today updates.

For readers following Alkem Laboratories Company News, the company's profile in this dataset is defined through its sector, industry, market cap, earnings, return ratios and valuation metrics. That is enough to frame Alkem Laboratories Share Price News without adding unsupported business claims. Univest uses the same verified numbers to present a clean Stock Analysis view for the market.

Track Alkem Laboratories Share Price on Univest

Use Alkem Laboratories (ALKEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Alkem Laboratories Share Price Live on Univest with the latest share price, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield and shareholding pattern once available in the verified company page. Univest also keeps Alkem Laboratories Stock News, Financial Results, sector context and peer comparisons together for easier monitoring.

For investors reviewing Alkem Laboratories Share Price Update, Univest presents the company’s market insights in one place so the latest movements can be read against financial data, sector benchmarks and listed peers. That makes it a practical reference for Alkem Laboratories Stock Analysis and Alkem Laboratories Latest News.

Frequently Asked Questions

Why did Alkem Laboratories Share Price fall today?

Ans.  The supplied data shows Alkem Laboratories Share Price fell 2.13% today, but it does not establish a company-specific catalyst. The move is a verified price event, supported by the day's open, high, low, previous close and turnover.

What is Alkem Laboratories Share Price today?

Ans.  Alkem Laboratories Share Price today is Rs 5,298.75. It is down Rs 115.40, or 2.13%, from the previous close of Rs 5,414.15, according to the supplied market data. The previous close was Rs 5,414.15.

What is the market capitalisation of Alkem Laboratories?

Ans.  Alkem Laboratories has a market capitalisation of Rs 63,813.63 crore. The company is also classified as Large Cap in the supplied data, which is useful company-size context for readers following Alkem Laboratories Share Price.

How does Alkem Laboratories compare with sector benchmarks?

Ans.  Alkem Laboratories trades at a P/E of 30 versus the industry median of 31.9, while ROE at 18.29% and ROCE at 21.28% are above the benchmark medians. Its P/B of 4.53 is also above the benchmark median of 3.

Should investors track Alkem Laboratories Share Price on Univest?

Ans.  Investors tracking Alkem Laboratories Share Price can use Univest for live price updates, valuation ratios, financial results, sector context and peer comparisons. The platform keeps the verified data together for easier monitoring of Alkem Laboratories Stock News.